| 1 | Representative(s) Glorioso offered the following: |
| 2 |
|
| 3 | Amendment (with directory and title amendments) |
| 4 | Remove line(s) 187 through 198 and insert: |
| 5 | (12)(a) Investigator-initiated research grantees shall |
| 6 | reinvest annually 15 percent of the net royalty revenues, |
| 7 | including the revenues from the sale of stock from the licensing |
| 8 | or transfer of inventions, methods, processes, and other |
| 9 | patentable discoveries conceived or reduced to practice using |
| 10 | the research grant, in whole or in part, and to which the |
| 11 | grantee becomes entitled each year during the 20 years following |
| 12 | the effective date of the contract between the James and Esther |
| 13 | King Biomedical Research Program and the grantee. |
| 14 | (b) For purposes of this subsection, the term "net royalty |
| 15 | revenues" means all royalty revenues less the cost of obtaining, |
| 16 | maintaining, and enforcing related patent and intellectual |
| 17 | property rights, both foreign and domestic. |
| 18 | (c) The grantee shall annually submit to the Department of |
| 19 | Health a schedule of the shares of stock held by it as payment |
| 20 | of the royalty pursuant to paragraph (a) and report on any |
| 21 | trades or activity concerning such stock. |
| 22 | (d) Reinvestment payments made under this subsection shall |
| 23 | commence no later than 6 months after the grantee has received |
| 24 | the final disbursement and shall continue until the maximum |
| 25 | reinvestment has been paid. |
| 26 | (e) All reinvestment payments made pursuant to this |
| 27 | subsection shall be remitted to the Department of Health for |
| 28 | deposit in the General Revenue Fund. |
| 29 | (13) By June 1, 2009, the Division of Statutory Revision |
| 30 | of the Office of Legislative Services shall certify to the |
| 31 | President of the Senate and the Speaker of the House of |
| 32 | Representatives the language and statutory citation of this |
| 33 | section, which is scheduled to expire January 1, 2011. |
| 34 | (14) The Legislature shall review the performance, the |
| 35 | outcomes, and the financial management of the James and Esther |
| 36 | King Biomedical Research Program during the 2010 Regular Session |
| 37 | of the Legislature and shall determine the most appropriate |
| 38 | funding source and means of funding the program based on its |
| 39 | review. |
| 40 | (15) This section expires January 1, 2011, unless reviewed |
| 41 |
|
| 42 | ====== D I R E C T O R Y A M E N D M E N T ===== |
| 43 | Remove line(s) 136 and insert: |
| 44 | Statutes, is amended, and subsections (11) through (15) are |
| 45 |
|
| 46 | ======= T I T L E A M E N D M E N T ======= |
| 47 | Remove line(s) 19 and insert: |
| 48 | David Coley Cancer Research Program; providing for certain |
| 49 | percentage of reinvestment of grant funds awarded for |
| 50 | investigator-initiated research; providing for reinvestment |
| 51 | funds to be paid to the Department of Health for deposit into |
| 52 | the General Revenue Fund; providing for the |